by University of Miami Miller School of Medicine – Medical and Life Science News –
A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, according to a study conducted by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and colleagues.
%2F2023%2F06%2F17%2Fimage%2Fjpeg%2FLSPbytnMRmOsLsXMMbnpUmcGhxrDLir4qS5SXWsc.jpg&w=1920&q=75)

